SOSV At The Close Of 2024
The past year has been remarkable year for SOSV. In April, we announced SOSV’s $306 million Fund V, our largest yet.
Recent news
Announcing SOSV’s Biomanufacturing VC-Founder Matchup – April 21-25, 2025 (Virtual, Free)
Welcome to the Biomanufacturing Matchup Event, where biology meets bold ambition. EXPECTED > 200 startups | 200 investors | 1 week of virtual meetings | FreeUPDATE (APR.14) > There are already 250+ startups and 250+ investors registered! From sustainable jet fuel to protein production, from next-gen pharmaceuticals to high-performance biomaterials—there are few limits to what […]
IndieBio’s Halomine and Inso Biosciences win New York state funding for disease outbreak prevention
Two Cornell-based IndieBio startups Halomine (NY 01) and Inso Biosciences (NY 03) won support from the New York State Biodefense Commercialization Fund to develop solutions that will prevent future disease outbreaks like COVID-19, the Cornell Daily Sun reported in the article “NYS Funds Cornell Startups To Combat New Disease Outbreaks”. Halomine’s primary technology, HaloFilm, extends […]